Corporate News
Senores Pharmaceuticals Limited recently announced several corporate actions, including the appointment of Dr. Viranchi Arvindbhai Shah as a director, who brings extensive experience in the pharmaceutical sector. The company also formally approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026 (ESOS 2026), granting 4,72,000 options, representing 1% of fully diluted equity, with a potential discount of up to 50% on the market price. Furthermore, Senores Pharmaceuticals intends to incorporate a wholly-owned subsidiary in Mexico for pharmaceutical product supply and distribution, and plans to establish a subsidiary in Canada with at least 51% ownership, also for pharmaceutical distribution. Both international ventures will require regulatory approvals and involve cash investments.